MoFo Life Sciences

September 30, 2024 - Biotech, Corporate + Venture Capital, Data Analytics, Startup
Life Sciences MoForum 2024 | San Diego: The State of the Life Sciences Industry
By: Erin M. Bosman, Jim Krenn and Karen G Potter Ph.D.
On September 24, 2024, Morrison Foerster hosted another installment of its premier MoForum series at the firm’s San Diego office. Mayor Todd Gloria shared his vision for San Diego’s commitment to the industry. The event featured expert panel discussions on cutting-edge scientific developments, market
... ›
April 30, 2024 - Corporate + Venture Capital, Employment, Financing, Global, Intellectual Property, Litigation, Privacy + Data Security, Regulatory, Startup
When Your Life Sciences Are on the Line: Protecting Your Company’s Most Valuable Asset: Trade Secrets
By: Kate Driscoll, Nathaniel R. Mendell and Jim Krenn
MoFo partners Kate Driscoll and Nate Mendell launched the MoFo life sciences podcast When Your Life Sciences Are on the Line this week, and Episode 1 is now available. The podcast features interviews with legal experts who share insights and advice you just might
... ›
December 09, 2022 - Agtech, Financing, Startup
Financing Options in the Alternative Protein Industry
By: Simon Arlington and Michelle Si-Ting Luo
This article is Part B of the fifth alert in our series of alerts focussed on the alternative protein industry. While Part A provided an overview of financing options in the industry, this Part B considers a variety of key financing options in more
... ›
November 11, 2022 - Agtech, Intellectual Property, Startup, Corporate + Venture Capital
Top Three IP Issues for AgTech Startups
By: Matthew A. Ferry and Edith A. Pierre-Jerome Ph.D.
Innovation, agriculture, and technology took center stage at San Diego’s first AgTech Hackathon. The event took place October 21 – 23 in the city of Escondido, a key farming hub in San Diego County looking to attract agtech startups to the region. The event
... ›
October 21, 2022 - Agtech, Financing, Startup
Financing Options for an Early Stage Company in the Alternative Protein Industry
By: Simon Arlington and Michelle Si-Ting Luo
Having a clear picture of financing options is key for early-stage companies and will be relevant to players in the alternative protein industry generally, given the significant amounts of investment that the industry has seen in recent years (a record US $5bn was invested
... ›
December 04, 2020 - Licensing + Commercial, Corporate + Venture Capital, COVID-19, Startup
Navigating Transaction and Licensing Issues in a COVID-19 World and Raising Angel Investments
By: Jim Krenn, Matt Karlyn and Michael Ward Ph.D.
Session 2 of the GSAS Harvard Biotech Club and Morrison & Foerster course on Legal Topics for Scientists, Entrepreneurs, and Start Ups was led by Transactions and Licensing partner Matt Karlyn and focused on how to navigate commercial life sciences transactions and licensing issues in
... ›
November 17, 2020 - United States, Corporate + Venture Capital, United Kingdom, Startup, Intellectual Property
GSAS Harvard Biotech Club and Morrison & Foerster’s New Course
By: Andrew Boyd, Alfredo B. D. Silva, Anita Choi and Michael Ward Ph.D.
MoFo & GSAS Harvard Biotech Club’s new course, “ Legal Topics for Scientists, Entrepreneurs, and Start Ups ,” started on November 11, with more than 100 life sciences graduate students, post-docs, and industry professionals. The Harvard Biotech Club is a student organization that seeks to
... ›
September 22, 2020 - Licensing + Commercial, United States, FDA, Startup, Data Analytics, Intellectual Property
GSAS Harvard Biotech Club and Morrison & Foerster’s Patent Course Off to a Roaring Start!
By: Michael Ward Ph.D., Matt Karlyn, Janet Xiao Ph.D., Matthew A. Chivvis, Jie Zhou Ph.D., Anna Yuan and Jillian A. Pesin-Fulop Ph.D.
More than 120 life sciences graduate students, post-docs and industry professionals attended the first class of a six part Patent Law Course offered by Morrison & Foerster and the GSAS Harvard Biotech Club on September 16, 2020. The Harvard Biotech Club is a student
... ›
January 24, 2018 - United States, Startup, Biotech, Pharma, Regulatory, Intellectual Property
Life Sciences Startups: Patent, FDA Considerations
By: Lisa N. Silverman Ph.D.
Innovator companies at all stages seek patent protection in order to limit market competition. Many early-stage companies seek patent protection with the additional goal of attracting investment. However, even if patent filings are accelerated in order to raise funds, it is important that early-stage
... ›
December 08, 2017 - United States, Corporate + Venture Capital, Startup, Intellectual Property, Financing
Startup diligence is more than ‘basic IP diligence’
In technology-based startup companies, the strength and integrity of a company’s IP portfolio is a key indicator of its enterprise value. Wise investors closely scrutinize the IP of their targets by doing basic IP diligence. But doing only basic diligence can leave investors blind
... ›

Topic Archives: Startup

Life Sciences MoForum 2024 | San Diego: The State of the Life Sciences Industry

By: Erin M. Bosman, Jim Krenn and Karen G Potter Ph.D.

When Your Life Sciences Are on the Line: Protecting Your Company’s Most Valuable Asset: Trade Secrets

By: Kate Driscoll, Nathaniel R. Mendell and Jim Krenn

Financing Options in the Alternative Protein Industry

By: Simon Arlington and Michelle Si-Ting Luo

Top Three IP Issues for AgTech Startups

By: Matthew A. Ferry and Edith A. Pierre-Jerome Ph.D.

Financing Options for an Early Stage Company in the Alternative Protein Industry

By: Simon Arlington and Michelle Si-Ting Luo

Navigating Transaction and Licensing Issues in a COVID-19 World and Raising Angel Investments

By: Jim Krenn, Matt Karlyn and Michael Ward Ph.D.

GSAS Harvard Biotech Club and Morrison & Foerster’s New Course

By: Andrew Boyd, Alfredo B. D. Silva, Anita Choi and Michael Ward Ph.D.

GSAS Harvard Biotech Club and Morrison & Foerster’s Patent Course Off to a Roaring Start!

By: Michael Ward Ph.D., Matt Karlyn, Janet Xiao Ph.D., Matthew A. Chivvis, Jie Zhou Ph.D., Anna Yuan and Jillian A. Pesin-Fulop Ph.D.

Life Sciences Startups: Patent, FDA Considerations

By: Lisa N. Silverman Ph.D.

Startup diligence is more than ‘basic IP diligence’